Delivery Order SPE2DB24D2205-SPE2DB25FEHMD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,629.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency awarded a $43,196.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This non-set-aside contract, awarded on September 17, 2025, is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $11,054.82 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a $9,469.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Ondansetron ODT 4 mg, an antiemetic medication commonly used in military and veteran healthcare settings. The contract, awarded on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a non-set-aside competitive award and serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $23,438.54. This is a firm fixed price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $25,523.93 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg. This competitively awarded, non-set-aside contract utilizes firm fixed price terms with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,791.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count packages) with a completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $2,283.84. This non-competitive, firm fixed-price delivery order was awarded on April 30, 2025, with an ultimate completion date of May 1, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $18,875.65 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count) with an ultimate completion date of September 10, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHMDDelivery Order
The Defense Logistics Agency awarded a $9,278.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron HCL 4 mg, an antiemetic medication commonly used in military and veteran healthcare settings. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and healthcare system procurement through DLA's Medical Supply Chain. The company holds significant capacity to fulfill federal medical supply requirements across multiple therapeutic domains, supplying everything from specialty medications and generic drugs to vaccines and medical devices. This delivery order for Ondansetron HCL reflects the contractor's ongoing role in supporting Defense Health Agency operations and other government healthcare systems through its prime IDC vehicle, which enables flexible fulfillment of pharmaceutical needs across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/12/25 |